Eligo Bioscience
Developer of antibiotics designed to treat microbiome precision and bacteria-associated diseases. The company's antibiotics combine sequencing systems with engineered phage capsids, to develop antimic...
Valuation
$0
Share Price
N/A
Total Raised
$56.5M
Last Round
N/A